156 related articles for article (PubMed ID: 10442852)
1. Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man.
Schmetterer L; Dallinger S; Polak K; Eichler HG; Wolzt M
Nitric Oxide; 1999 Jun; 3(3):209-15. PubMed ID: 10442852
[TBL] [Abstract][Full Text] [Related]
2. Predictors of inotropic and chronotropic effects of NG-monomethyl-L-arginine.
Brillante DG; O'Sullivan AJ; Johnstone MT; Howes LG
Eur J Clin Invest; 2009 Apr; 39(4):273-9. PubMed ID: 19292882
[TBL] [Abstract][Full Text] [Related]
3. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
Hjorth Lassen L; Klingenberg Iversen H; Olesen J
Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
Whalen EJ; Bates JN; Johnson AK; Lewis SJ
Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
[TBL] [Abstract][Full Text] [Related]
5. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
[TBL] [Abstract][Full Text] [Related]
7. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man.
Jilma B; Dirnberger E; Eichler HG; Matulla B; Schmetterer L; Kapiotis S; Speiser W; Wagner OF
Thromb Haemost; 1997 Oct; 78(4):1268-71. PubMed ID: 9364996
[TBL] [Abstract][Full Text] [Related]
8. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
9. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins.
Chalon S; Tejura B; Moreno H; Urae A; Blaschke TF; Hoffman BB
Br J Clin Pharmacol; 1999 Jan; 47(1):91-8. PubMed ID: 10073745
[TBL] [Abstract][Full Text] [Related]
11. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and cardiac muscarinic control in humans.
Chowdhary S; Marsh AM; Coote JH; Townend JN
Hypertension; 2004 May; 43(5):1023-8. PubMed ID: 15037554
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
Harding SE; Davies CH; Money-Kyrle AM; Poole-Wilson PA
Cardiovasc Res; 1998 Dec; 40(3):523-9. PubMed ID: 10070493
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in exercise-induced vasodilation in man.
Koller-Strametz J; Matulla B; Wolzt M; Müller M; Entlicher J; Eichler HG; Schmetterer L
Life Sci; 1998; 62(11):1035-42. PubMed ID: 9515561
[TBL] [Abstract][Full Text] [Related]
15. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
16. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
Larsen T; Mose FH; Bech JN; Pedersen EB
Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
[TBL] [Abstract][Full Text] [Related]
17. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
19. Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium.
Kilter H; Lenz O; La Rosée K; Flesch M; Schwinger RH; Mädge M; Kuhn-Regnier F; Böhm M
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):308-12. PubMed ID: 8584047
[TBL] [Abstract][Full Text] [Related]
20. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.
Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K
Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
